title: Red face and fungi infection.
abstract: Red face syndrome is characterized by an erythematous dermatitis that is produced by different entities. These include rosacea, seborrheic dermatitis, contact dermatitis, atopic dermatitis, psoriasis, cutaneous lupus, photodermatosis, post-topical steroid dermatosis, demodicosis, borderline borderline (BB) leprosy, mastocytosis, carcinoid, postneoplasia flushing, cutaneous lymphoma, tineas, ulerythema ophryogenes, and psychosomatic flushing. Red face is a relatively common dermatologic manifestation. Our goal is to review tinea corporis and other fungi that affect this region causing facial erythema and its therapeutic management.
authors.affiliation: Department of Dermatology, Dr. Jose Eleuterio Gonzalez University Hospital, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico. Electronic address: owelsh@yahoo.com.
authors.forename: Oliverio
authors.initials: O
authors.lastname: Welsh
authors.affiliation: Department of Dermatology, Dr. Jose Eleuterio Gonzalez University Hospital, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
authors.forename: Lucio
authors.initials: L
authors.lastname: Vera-Cabrera
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D003881:Dermatomycoses / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D004890:Erythema / Q000453:epidemiology / Q000382:microbiology* / Q000503:physiopathology; D005148:Facial Dermatoses / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D005260:Female; D005658:Fungi / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D011379:Prognosis; D018570:Risk Assessment; D012393:Rosacea / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents